Category: General Pharmaceuticals
Europe General Pharmaceuticals
-
European Pharma Handbook 2025
European Pharma Handbook 2025 A data-rich report that gives you insight into the structures,trends, and regulations driving the European pharmaceutical market. Extensive profiles of companies and each company's senior officials. Read More
-
Cannabis in Italy
... Italian doctors, who were major prescribers of medical cannabis, retired and there was no generational turnover. This included eight doctors who had been prescribing since 2013 and were a point of reference for many patients. ... Read More
-
Cannabis in Greece
... allowed. Despite scope being rather limited in 2024, the introduction of medical cannabis in Greece is a step forward and might open the door to further regulatory changes in line with other European cannabis markets ... Read More
-
Cannabis in Portugal
... and other non-intoxicating cannabinoids products became stagnant in Portugal, due to the continuous scrutiny from authorities, products being out of stock and strong price reductions, among other factors. Conversely, the presence of emerging cannabinoids became ... Read More
-
Cannabis in the Czech Republic
... ambitious plans to establish a legal commercial market for cannabis may have been scaled back. Despite this, there is a growing consensus among experts that liberalising cannabis could significantly diminish the black market, which has ... Read More
-
Cannabis in the Netherlands
... habits. While price increases for CBD were more modest than in 2023, they were still significant enough to put pressure on volume growth. Euromonitor International's Cannabis in Netherlands market report offers a comprehensive guide to ... Read More
-
Cannabis in Switzerland
... cannabis. Adult-use cannabis recorded the fastest growth in value and volume terms in 2024. Adult-use cannabis’ performance has been shaped by the implementation of pilot tests. Euromonitor International's Cannabis in Switzerland market report offers a ... Read More
-
Cannabis in France
... at EUR6.7 billion. Illicit cannabis is estimated to account for around 90% of the overall local market. In France, the production, import and sale of recreational and adult-use cannabis continues to be forbidden, and this ... Read More
-
Cannabis in Germany
... illicit market, the absence of legal production facilities and/or an infrastructure for cannabis distribution forces consumers to continue buying via the black market. As the economy is not performing well and people are generally unsatisfied ... Read More
-
Cannabis in the United Kingdom
... Nevertheless, cost and accessibility issues continue to hamper uptake of medical cannabis, which is heavily skewed towards private channels rather than the public healthcare system, the NHS. Euromonitor International's Cannabis in United Kingdom market report ... Read More
-
Cannabis in Spain
... for medical cannabis is on the horizon, the lack of political will to regulate recreational cannabis results in a strong illegal market that accounts for an overwhelming share of total market value. Meanwhile, the fast-growing ... Read More
-
Portugal Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Portugal) report will tell you the companies that have a declining financial ... Read More
-
Cannabis in Belgium
... strict regulations, although the availability of products remains limited. While adult-use cannabis remains illegal in Belgium, legalisation is not anticipated in the near future due to a complex political environment, which in turn contributes to ... Read More
-
Belgium Pharmaceuticals - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Pharmaceuticals (Belgium) report will tell you the companies that have a declining financial ... Read More
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very ... Read More
-
2024 Europe Medical Marijuana Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Germany Cannabis Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Europe Pharmaceutical Excipients Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 France Pharmaceutical Excipients Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United Kingdom Pharmaceutical Excipients Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United Kingdom Medical Marijuana Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 France Legal Cannabis Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 France Medical Marijuana Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Europe Cannabis Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Germany Medical Marijuana Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
Research Assistance
